Oncoinvent announces positive interim results from phase 1/2a studies of Radspherin for treatment of peritoneal carcinomatosis: Oslo, Norway Tuesday, November 12, 2024, 18:00 Hrs ...

The 5-year OS rates were 46% in the HIPEC group versus 38% in the no-HIPEC group, they noted in Lancet Oncology. The trial ...

mdanderson.org; Jaffer A Ajani, Department of GI Medical Oncology, UT MD Anderson Cancer Center, Houston, TX, 77030, USA; jajani{at}mdanderson.org Objective Peritoneal carcinomatosis (PC; malignant ...

The multifocality and irregularity of peritoneal carcinomatosis complicates the within-lesion reproducibility of ADC measurements and the feasibility of accurate serial comparisons. Robust ...

IMNN READ THE FULL IMNN RESEARCH REPORT Business Update Preparations Underway for Phase 3 Ovarian Cancer Trial; Set to Initiate in 1Q25 Imunon, Inc. (NASDAQ:IMNN) previously reported positive topline ...

Leptomeningeal carcinomatosis (LC), sometimes referred to as carcinomatous meningitis ... Currently recommended interventions to reduce CSF pressure include repeated lumbar punctures and placement of ...

Researchers at University of California San Diego School of Medicine found an FDA-approved drug used to treat breast cancer ...

This single-arm study included 167 patients with epithelial ovarian, fallopian tube, or primary peritoneal cancer. The ...

Peritoneal metastases are often the first presentation of ovarian malignancy. Evaluating the extent of disease critically determines tumor resectability and can also predict outcome. Standard CT ...

I don’t fully understand why so many people would faint from horror at the thought of hearing a dog screaming in agony but ...

Generalised eruptive keratoacanthoma of Grzybowski (GEKA) is a rare disease characterised by the sudden appearance of ...

or primary peritoneal cancer, who have previously been treated with between one and three prior systemic treatment regimens can be treated with ELAHERE. ELAHERE was evaluated in the pivotal SORAYA ...